U.S. industry explainer
How medication regimen review works—and what the software needs to support.
The work does not end when a pharmacist spots a concern. A useful MRR system has to connect current resident context, professional review, a clear report, the right recipients, a documented response, and visible follow-through.
Federal baseline, simplified
What the current rule anchors.
These points summarize the nursing-facility framework in 42 CFR § 483.45 and CMS interpretive guidance. They are not a complete compliance checklist, and they should not be generalized to every long-term-care setting.
A licensed pharmacist reviews every resident at least monthly
For nursing facilities covered by 42 CFR § 483.45, the drug regimen of each resident must be reviewed at least once a month, and the review must include the resident's medical chart. CMS guidance says resident condition and medication risk can make more frequent review appropriate.
Primary sources42 CFR § 483.45CMS Appendix PP
Identified irregularities go into a separate written report
The pharmacist reports identified irregularities to the attending physician, the facility's medical director, and the director of nursing. The federal rule sets minimum report content: the resident, the relevant drug, and the irregularity identified.
Primary sources42 CFR § 483.45
The response belongs in the resident's medical record
The attending physician must document that the irregularity was reviewed and what action was taken. If the medication is not changed, the rule says the physician should document the rationale. A status inside an MRR product may help coordination, but it is not automatically the required medical-record entry.
Primary sources42 CFR § 483.45CMS Appendix PP
The facility owns timing and urgent-action procedures
The facility must maintain policies and procedures for the monthly review, including time frames for the steps and what the pharmacist does when an irregularity needs urgent action to protect a resident. Software has to fit that procedure; it does not define it.
Primary sources42 CFR § 483.45CMS Appendix PP
The review reaches beyond a medication list
The federal framework addresses unnecessary drugs, including excessive dose or duration, inadequate indication or monitoring, and adverse consequences. It also contains specific requirements for psychotropic drugs, gradual dose reduction, behavioral interventions, and certain PRN orders.
Primary sources42 CFR § 483.45
Deliberate boundary: § 483.45 also addresses broader pharmacy services, controlled-drug records, medication errors, labeling, and storage. This page focuses on the resident-level MRR loop and software decisions around it; it is not a summary of every pharmacist or facility duty. The federal MRR provision says “licensed pharmacist”; state law can add licensing, scope, or setting-specific requirements.
Nearby obligations
MRR sits inside a larger facility system.
Recordkeeping, quality improvement, and antibiotic stewardship help explain why exports, history, analytics, and focused reports matter. They do not make those software features a complete compliance program.
Federal rule
Medical records must remain usable and safeguarded
The nursing facility must maintain records that are complete, accurate, readily accessible, systematically organized, confidential, and safeguarded. That makes availability, release history, correction behavior, retention, and export practical software questions.
Primary sources42 CFR § 483.70(h)
Federal rule; software is only support
QAPI is a facility program, not a dashboard feature
The federal rule requires a data-driven quality assurance and performance improvement program. MRR analytics may contribute useful signals, but no particular MRR dashboard or product is mandated and reporting alone is not the program.
Primary sources42 CFR § 483.75
Federal rule; software is only support
Antibiotic monitoring sits in a wider stewardship system
The infection-control rule includes antibiotic-use protocols and monitoring. A pharmacist report can support that work, but the report is not a substitute for the facility's infection prevention and antibiotic stewardship program.
Primary sources42 CFR § 483.80
The review-to-response loop
The workflow, end to end.
The first five stages translate the federal baseline into an operating flow. The final stage is the continuity work that keeps completed and unresolved reviews usable over time.
Assemble current resident context
Bring together the active medication profile and the chart context needed for a real review: orders, administration records, diagnoses, allergies, notes, labs, monitoring, changes in condition, and care transitions as applicable.
What the software should make easierShow when and where each input came from. A polished screen built on stale, partial, or manually re-keyed data can move the burden rather than remove it.
Perform the pharmacist review
The pharmacist evaluates the regimen in the resident's clinical context, looking for actual or potential medication-related irregularities. The software can organize evidence and prompts; the licensed pharmacist supplies the judgment.
What the software should make easierSupport the review types and clinical context the practice actually uses without turning a checklist into a substitute for assessment.
Document the review and any finding
Record that the review occurred. CMS guidance expects a signed and dated statement when no irregularity is found. When one is found, describe it clearly enough for the receiving care team to understand the resident, relevant medication, concern, and proposed next step.
What the software should make easierPreserve authorship, date, status, and the exact released output. Ask how corrections and later revisions appear in history.
Route and escalate
Send the separate written finding to the required recipients and use the facility's urgent pathway when delay could put the resident at risk. Routine monthly delivery and urgent communication are not the same workflow.
What the software should make easierMake audience, priority, delivery method, and unresolved handoffs visible. Confirm what is delivered by the product and what still happens outside it.
Capture the response and action
The attending physician reviews the irregularity and documents the action or, when there is no change, the rationale in the medical record. Facility staff then carry out and monitor the resulting plan as appropriate.
What the software should make easierKeep an operational response or outcome linked to the original finding, while remaining clear about which system is the legal medical record.
Follow through and preserve continuity
Unresolved work should remain findable. Over time, resident-level history can support coverage, facility conversations, and quality review when the data and permissions allow it.
What the software should make easierLet another authorized pharmacist understand what happened, what was sent, what came back, and what still needs attention—then export that history when the practice changes systems.
Why the workflow matters
A sent report is a handoff—not the finish line.
The resident-safety purpose of MRR depends on more than identifying a concern. The concern must reach responsible people, urgent issues must use the urgent path, the physician's decision must be documented, and the resulting work must stay visible long enough to be acted on and understood.
No software feature guarantees these outcomes; data quality, clinical judgment, facility process, and human response still determine what happens.
What matters in the software
Evaluate the joins between the steps.
Templates and feature counts are easy to demonstrate. The consequential questions are how information arrives, how work moves, what evidence remains, and what happens when the normal path breaks.
Data freshness and completeness
Establish whether data is typed, uploaded, converted, or supplied through a live interface; which systems and fields are named; how exceptions appear; and who reconciles missing or conflicting information.
Fit with the whole loop
Test review, documentation, routine routing, urgent escalation, response, follow-up, and coverage. A strong review editor can still leave the hardest handoffs in email and spreadsheets.
Useful, traceable output
Reports should suit their real audiences. Ask what is saved when a report is released, whether delivery is recorded, and how amendments differ from the original artifact.
Open-work visibility
Confirm how the product distinguishes sent, acknowledged, accepted, declined, deferred, implemented, and closed work—and which of those states are recorded by people rather than inferred.
Access, privacy, and security evidence
Evaluate roles, user lifecycle, authentication, activity history, backups, recovery, incidents, subcontractors, and contract terms. Where a vendor handles PHI as a business associate, a BAA is important but is not proof of complete security or compliance.
Continuity, cost, and exit
Include migration, setup, training, support, manual preparation, coverage, optional billing tools, data export, retention, and termination help in the operating-cost decision—not only the subscription price.
The boundary
What software cannot establish.
These limits are important because product marketing often compresses a clinical, operational, and regulatory system into one reassuring label.
It cannot replace professional judgment
Rules, alerts, templates, and AI-assisted features can surface or structure information. They do not perform the licensed pharmacist's complete review or decide what is clinically appropriate for a resident.
It cannot make a facility compliant
Compliance depends on people, policies, data, communication, response, documentation, security, and the facts of the setting. Buying a product does not satisfy that system of responsibilities.
It cannot validate its own claims
A vendor's statements about an integration, audit trail, HIPAA, encryption, or automation are evidence to investigate. Ask for a demonstration, current documentation, contract language, and appropriate independent review.
A useful software demo
Ask every finalist to prove one complete loop.
Use a representative resident and facility scenario, including an urgent exception. Give each vendor the same starting data and ask the same people to observe the same steps. Record what was demonstrated, what depends on another system, and what remains a promise for implementation.
- Show the source data arriving.Include a missing or conflicting item.
- Complete and release the review.Do not skip the no-finding path.
- Route routine and urgent work.Identify every recipient and handoff.
- Record the response.Separate software status from the medical record.
- Hand off and export.Let a covering user continue the work, then retrieve the history.
Primary sources
Check the authority, not just this summary.
These links were checked on July 10, 2026. Regulations and agency guidance can change. A state board or other regulator may impose additional or different requirements for a particular setting.
Electronic Code of Federal Regulations
42 CFR § 483.45 — Pharmacy services
Federal nursing-facility requirements for pharmacy services, drug regimen review, unnecessary drugs, and psychotropic drugs.
Checked July 10, 2026
Centers for Medicare & Medicaid Services
State Operations Manual, Appendix PP — Guidance to Surveyors for Long Term Care Facilities
See the guidance for medication regimen review, reporting irregularities, unnecessary medications, and psychotropic medications.
Checked July 10, 2026
U.S. Department of Health and Human Services, Office for Civil Rights
Is a software vendor a business associate of a covered entity?
Explains when a software vendor's access to protected health information can create a business-associate relationship.
Checked July 10, 2026
U.S. Department of Health and Human Services, Office for Civil Rights
Summary of the HIPAA Security Rule
A current-rule overview of administrative, physical, and technical safeguards for electronic protected health information.
Checked July 10, 2026
Electronic Code of Federal Regulations
42 CFR § 483.70(h) — Medical records
Nursing-facility requirements for complete, accurate, accessible, organized, confidential, and safeguarded medical records.
Checked July 10, 2026
Electronic Code of Federal Regulations
42 CFR § 483.75 — Quality assurance and performance improvement
The federal framework for a nursing facility's data-driven QAPI program.
Checked July 10, 2026
Electronic Code of Federal Regulations
42 CFR § 483.80 — Infection control
Includes antibiotic-use protocols and a system to monitor antibiotic use.
Checked July 10, 2026
Found a change or mistake? Send the exact statement and a current primary source to consultantpharmacistsoftware@tinycall.com. We will review material corrections and update the checked date when appropriate.